News & Press Releases
Filter by:
Will FDA Adverse Event Data Release Mean More Lawsuits?
January 18, 2017
In this Law360 feature article, Joanne Hawana and Dan Herling discuss the release of data regarding adverse events received by the FDA’s Center for Food Safety and Applied Nutrition, whether the timing of the release matters, and what greater AER transparency means for litigations risks.
The FDA targeted DTC, video, unapproved drug promotion in 2016
January 18, 2017
This article, published in Medical Marketing & Media, addresses the FDA’s new approach to regulating drugmakers’ advertising and promotion. Mintz FDA team members Bethany Hills and Joanne Hawana offer insight.
Health Care Enforcement Review And 2017 Outlook: Part 3
January 18, 2017
This is the third installment of a four-part series recapping key government policies, regulations and enforcement actions from 2016 and discussing their potential impacts on 2017.
Health Care Enforcement Review And 2017 Outlook: Part 2
January 17, 2017
Three attorneys from Mintz author the second installment of a four-part series recapping key government policies, regulations and enforcement actions from 2016 and discussing their potential impacts on 2017.
Mintz Nabs Ex-Dechert IP Partner In Silicon Valley
January 17, 2017
This Law360 feature article highlights Stephen Akerley, who joined Mintz as a Member in the firm’s San Francisco office. Steve’s work involves IP law and patent litigation practices, and has applications in technology and manufacturing fields.
Offensive TMs At High Court: Everything You Need To Know
January 17, 2017
Susan Neuberger Weller is among sources quoted in this article discussing a high-profile trademark case involving the Washington Redskins and the band The Slants.
